Reduced serum levels of Interleukin 17 in patients with osteonecrosis of the jaw and in multiple myeloma subjects after bisphosphonates administration.
Oteri
Giacomo
G
Allegra
Alessandro
A
Bellomo
Giacomo
G
Alonci
Andrea
A
Nastro
Enrico
E
Penna
Giuseppa
G
Catalfamo
Luciano
L
Cicciù
Domenico
D
De Ponte
Francesco Saverio
FS
Musolino
Caterina
C
D000368:Aged; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D020381:Interleukin-17 / Q000097:blood*; D007571:Jaw Diseases / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood* / Q000188:drug therapy*; D010020:Osteonecrosis / Q000139:chemically induced*
D004164:Diphosphonates; D020381:Interleukin-17